Ephedra: Who is Protecting the American Consumers? : Hearing Before the Oversight of Government Management, Restructuring, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Seventh Congress, Second Session, October 8, 2002
United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia
U.S. Government Printing Office, Jan 1, 2003 - Consumer protection - 190 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
action adverse event reports advertising Advisory AERs Agency ANOVA ANOVA Timexgroup assessment associated Astrup athletes Baseline blood pressure body fat body weight caffeine Canadian cardiac arrhythmias cardiovascular clinical trials combination consumers containing ephedrine alkaloids CRAWFORD death dietary supplements containing dosage dose Drug Administration DSHEA enforcement ephedra products ephedra-containing products ephedra/caffeine Ephedra/ephedrine FDA's Federal Food and Drug Health Canada heart rate hemorrhagic stroke herbal group herbal treatment Holter monitor Huang increased ingredients issued Journal of Obesity label LANNY DAVIS manufacturers Metabolife Metabolife's mmHg myocardial infarction natural health products NCAA obesity over-the-counter over-the-counter drugs phenylpropanolamine placebo placebo group products containing ephedra pseudoephedrine question recommended regulations regulatory risk RONALD DAVIS safe safety and efficacy Senator DURBIN significant street drugs stroke Subcommittee subjects supplements containing ephedra synthetic ephedrine testimony Timexgroup interaction warning week weight loss Yellow Jackets